Granza Bio
Granza Bio is a biotech company in San Francisco, United States, founded in 2024. It has raised $7.1M across 1 round, most recently a $7.1M Seed in July 2024.
Advancing Therapeutic Delivery
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Website
- granzabio.com
- Total Funding
- $7.1M
- Last Round
- $7.1M SeedJul 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
Granza Bio is a biotechnology company developing a novel delivery "shell" platform to direct therapeutic cargo to specific tissues. Their proprietary delivery vehicles are designed using non-immunogenic proteins equipped with a targeting receptor, achieving targeted tropism to organs of interest. These vehicles offer higher stability than conventional lipid nanoparticles (LNPs) and can encompass a variety of cargo, including proteins, DNA, and RNA. For their lead candidate, Granza Bio is leveraging the discovery of the immune system's powerful suite of weapons, "attack particles". Utilizing their advanced delivery platform, they aim to target these "attack particles" against a range of diseases such as cancer, autoimmune disorders, and infections. Interested to know more? Get in touch info@granzabio.com!
Summary
It lists 1–10 employees. It has raised $7.1M in total across 1 round, most recently a $7.1M Seed round in Jul 2024. Investors include Felicis Ventures, Refactor Capital and Y Combinator.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2024
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/granza-bio-yc-w24"><img src="https://indexed.vc/api/badge/company/granza-bio-yc-w24" alt="Granza Bio on Indexed.vc" width="260" height="76" /></a>